Antiplatelet and anticoagulant therapy in patients with advanced heart failure

Thrombosis Research

Volumn 116, Issue 4, 2005, Pages 275-277

  Lip, Gregory Y H ^a   Chung, Irene ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; WARFARIN;

ANTICOAGULANT THERAPY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG EFFICACY; EDITORIAL; HEART FAILURE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; STROKE; THROMBOSIS;

ANTICOAGULANTS; ASPIRIN; HEART FAILURE, CONGESTIVE; HUMANS; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME; WARFARIN;

EID: 22244474263     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.12.022     Document Type: Editorial

References (22)

1. G.Y.H. Lip, and C.R. Gibbs Does heart failure confer a hypercoagulable state? JACC 33 1999 1424 1426
2. The Consensus Trial Study Group Effects of enalapril on mortality in severe congestive heart failure N. Engl. J. Med. 316 1987 1429 1436
3. B.F. Uretsky, K. Thygesen, P.W. Armstrong, J.G. Cleland, J.D. Horowitz, and B.M. Massie Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial Circulation 102 2000 611 616
4. B.S. Chin, N.A. Chung, C.R. Gibbs, A.D. Blann, and G.Y. Lip Vascular endothelial growth factor and soluble P-selectin in acute and chronic congestive heart failure Am. J. Cardiol. 90 2002 1258 1260
5. A.Y. Chong, A.D. Blann, J. Patel, B. Freestone, E. Hughes, and G.Y. Lip Endothelial dysfunction and damage in congestive heart failure: relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage, and brain natriuretic peptide Circulation 110 2004 1794 1798
6. B.S. Chin, A.D. Blann, C.R. Gibbs, N.A. Chung, D.G. Conway, and G.Y. Lip Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure Eur. J. Clin. Investig. 33 2003 941 948
7. G.Y. Lip, and C.R. Gibbs Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review QJM 95 2002 451 459
8. G.Y. Lip, and C.R. Gibbs Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a cochrane systematic review QJM 95 2002 461 468
9. J.G. Cleland, I. Findlay, S. Jafri, G. Sutton, R. Falk, and C. Bulpitt The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure Am. Heart J. 148 2004 157 164
10. J.G. Cleland, J. Ghosh, N. Freemantle, G.C. Kaye, M. Nasir, and A.L. Clark Clinical trials update and cumulative meta-analysis from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failure Eur. J. Heart. Fail. 6 4 2004 501 508
11. D.L. Dries, M.J. Domanski, M.A. Waclawiw, and B.J. Gersh Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure Am. J. Cardiol. 79 1997 909 913
12. W.B. Dunkman, G.R. Johnson, P.E. Carson, G. Bhat, L. Farrell, and J.N. Cohn Incidence of thromboembolic events in congestive heart failure Circulation 87 1993 VI94 VI101
13. M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown, and T.E. Cuddy Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction N. Engl. J. Med. 327 1992 669 677
14. R.H. Falk, A. Polak, P.K. Tandon, and M. Packer The effect of warfarin on prevalence of stroke in patients with severe heart failure JACC 21 1993 218A
15. M. Echemann, F. Alla, S. Briancon, Y. Juilliere, J.M. Virion, and P.M. Mertes Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction Eur. J. Heart Fail. 4 2002 647 654
16. R.A. de Boer, G. Tjeerdsma, F.W.A. Verheugt, and D.J. van Veldhuisen Both antiplatelet and anticoagulant therapy favorably affect outcome in patients with advanced heart failure Thromb. Research 116 2005 279 285 (this issue)
17. A.S. Al-Khadra, D.N. Salem, W.M. Rand, J.E. Udelson, J.J. Smith, and M.A. Konstam Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial J. Am. Coll. Cardiol. 31 1998 419 425
18. K.N. Nguyen, I. Aursnes, and J. Kjekshus Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) Am. J. Cardiol. 79 1997 115 119
19. M.D. Flather, S. Yusuf, L. Kober, M. Pfeffer, A. Hall, and G. Murray Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-inhibitor myocardial infarction collaborative group Lancet 355 2000 1575 1581
20. M. Guazzi, G. Marenzi, M. Alimento, M. Contini, and P. Agostoni Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin Circulation 95 1997 1930 1936
21. S. Kindsvater, K. Leclerc, and J. Ward Effects of coadministration of aspirin or clopidogrel on exercise testing in patients with heart failure receiving angiotensin-converting enzyme inhibitors Am. J. Cardiol. 91 2003 1350 1352
22. P.M. Pullicino, J.L. Halperin, and J.L. Thompson Stroke in patients with heart failure and reduced left ventricular ejection fraction Neurology 25 2000 288 294